% (Gain)/Loss from sales investment in subsidiary 70.62 52.14 9.36 197.48% Shares of loss in of associates 28.93 9.36 9.36 209.11% Financing Cost 69.37 67.70 67.70 2.47% (773.56) (609.40) (385.37) 42.60
% Selling and Administrative Expenses 88.19 102.45 102.45 -13.92% (300.78) (230.26) (55.46) 127.14% Non-operating income/expense 303.87 249.95 243.49 22.15% (Gain)/Loss from sales investment in subsidiary
) Comprises of gain on sale of investments, sale of investment in subsidiaries and sale of assets. (2) EBIT, EBIT margins, EBITDA, EBITDA margins, EBITDAR or EBITDAR margins are not standard measures, nor
net loss includes unrealized loss on foreign exchange of 19.29 million baht. Comparing with last year, the Company had a net loss of 64.72 million baht which includes unrealized gain on foreign exchange
had a net loss of 34.71 million baht in which there is a loss attributable for the equity holders of the Company of 34.72 million baht and the net loss includes an unrealized gain on foreign exchange of
prepared the production of B100 to follow the new standard of Monoglyceride content not exceeding 0.4%. Together with ability to efficiently manage raw material cost, gross profit was improved from the
400.34 % due to the financial situation that The appreciation during the 1st quarter of this year resulted in the company having more foreign exchange gain this year. Selling expenses of the company for
result Million Baht 2019 2018 Sales 1,748.29 1,905.09 Cost of Sales 1,636.11 1,756.98 Gross Margin 112.17 148.11 Gain (loss) on exchange rates 38.44 (26.43) Other Incomes 33.76 30.28 Total Revenues
result Million Baht 2018 2017 Sales 1,905.09 1,849.88 Cost of Sales 1,756.98 1,621.03 Gross Margin 148.11 228.85 Gain (loss) on exchange rates (26.43) 23.44 Other Incomes 30.28 27.42 Total Revenues